Fabry's disease differential diagnosis: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
Line 29: Line 29:
|[[Sialidosis]] (Juvenile foem)<ref name="pmid22452439">{{cite journal| author=Zampetti A, Orteu CH, Antuzzi D, Bongiorno MR, Manco S, Gnarra M | display-authors=etal| title=Angiokeratoma: decision-making aid for the diagnosis of Fabry disease. | journal=Br J Dermatol | year= 2012 | volume= 166 | issue= 4 | pages= 712-20 | pmid=22452439 | doi=10.1111/j.1365-2133.2012.10742.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22452439  }}</ref>
|[[Sialidosis]] (Juvenile foem)<ref name="pmid22452439">{{cite journal| author=Zampetti A, Orteu CH, Antuzzi D, Bongiorno MR, Manco S, Gnarra M | display-authors=etal| title=Angiokeratoma: decision-making aid for the diagnosis of Fabry disease. | journal=Br J Dermatol | year= 2012 | volume= 166 | issue= 4 | pages= 712-20 | pmid=22452439 | doi=10.1111/j.1365-2133.2012.10742.x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=22452439  }}</ref>
|
|
*Mean age : 2 years old
*Mean age<span> </span>: 2 years old
*Location: Diffuse
*Location: Diffuse
|
|
Line 83: Line 83:
|[[Chronic Venus insufficiency]]
|[[Chronic Venus insufficiency]]
|
|
* History taking
*
*
|
|
Line 89: Line 91:
|[[Rheumatic disorders]]
|[[Rheumatic disorders]]
|
|
* History taking
|
|
*Should Investigate accompanying symptoms
*Should Investigate accompanying symptoms
Line 96: Line 99:
| rowspan="10" |
| rowspan="10" |
*Severe neuropathic pain, Limb pain ( Acroparesthesia), Burning palms and soles
*Severe neuropathic pain, Limb pain ( Acroparesthesia), Burning palms and soles
*Exacerbate by high temperature  
*Exacerbate by high temperature


*Mean age: 10 years old
*Mean age: 10 years old
Line 110: Line 113:
|[[Fibromyalgia]]
|[[Fibromyalgia]]
|
|
* Absence of other Fabry's disease presentations ( [[Proteinuria]], [[Left ventricular hypertrophy|LVH]], [[angiokeratomas]].)
*Absence of other Fabry's disease presentations ( [[Proteinuria]], [[Left ventricular hypertrophy|LVH]], [[angiokeratomas]].)
|
|
|-
|-
|[[Headache]] ([[Cluster headache|Cluster]])
|[[Headache]] ([[Cluster headache|Cluster]])
|
|
* Attention to cluster diagnostic crateria
*Attention to cluster diagnostic crateria
|
|
|-
|-
|[[Migraine]]
|[[Migraine]]
|
|
* Should Investigate accompanying symptoms
*Should Investigate accompanying symptoms
|
|
* Both can have white matter lesions (WML) in [[Magnetic resonance imaging|MRI]]<ref name="pmid20464614">{{cite journal| author=Albano B, Dinia L, Del Sette M, Gandolfo C, Sivori G, Finocchi C| title=Fabry disease in patients with migraine with aura. | journal=Neurol Sci | year= 2010 | volume= 31 Suppl 1 | issue=  | pages= S167-9 | pmid=20464614 | doi=10.1007/s10072-010-0314-5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20464614  }}</ref>
*Both can have white matter lesions (WML) in [[Magnetic resonance imaging|MRI]]<ref name="pmid20464614">{{cite journal| author=Albano B, Dinia L, Del Sette M, Gandolfo C, Sivori G, Finocchi C| title=Fabry disease in patients with migraine with aura. | journal=Neurol Sci | year= 2010 | volume= 31 Suppl 1 | issue=  | pages= S167-9 | pmid=20464614 | doi=10.1007/s10072-010-0314-5 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20464614  }}</ref>
|-
|-
|Diabetic neuropathy
|Diabetic neuropathy
|
|
* Chronic progression  
*Chronic progression
|
|
* acute crisis episodes is more favorable in Fabry's disease<ref name="pmid21619592">{{cite journal| author=Burlina AP, Sims KB, Politei JM, Bennett GJ, Baron R, Sommer C | display-authors=etal| title=Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel. | journal=BMC Neurol | year= 2011 | volume= 11 | issue=  | pages= 61 | pmid=21619592 | doi=10.1186/1471-2377-11-61 | pmc=3126707 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21619592  }}</ref>
*acute crisis episodes is more favorable in Fabry's disease<ref name="pmid21619592">{{cite journal| author=Burlina AP, Sims KB, Politei JM, Bennett GJ, Baron R, Sommer C | display-authors=etal| title=Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel. | journal=BMC Neurol | year= 2011 | volume= 11 | issue=  | pages= 61 | pmid=21619592 | doi=10.1186/1471-2377-11-61 | pmc=3126707 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=21619592  }}</ref>
|-
|-
|Recurrent fever syndromes
|Recurrent fever syndromes
|
|
* Elevation of acute phase reactants<ref name="pmid30755957">{{cite journal| author=Graziani F, Ruggio A, Iaconelli A, Verrecchia E, Morrone A, Antuzzi D | display-authors=etal| title=Anderson-Fabry's Disease: A Rare but Treatable Case of Fever of Unknown Origin. | journal=Eur J Case Rep Intern Med | year= 2017 | volume= 4 | issue= 7 | pages= 000645 | pmid=30755957 | doi=10.12890/2017_000645 | pmc=6346910 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30755957  }}</ref>
*Elevation of acute phase reactants<ref name="pmid30755957">{{cite journal| author=Graziani F, Ruggio A, Iaconelli A, Verrecchia E, Morrone A, Antuzzi D | display-authors=etal| title=Anderson-Fabry's Disease: A Rare but Treatable Case of Fever of Unknown Origin. | journal=Eur J Case Rep Intern Med | year= 2017 | volume= 4 | issue= 7 | pages= 000645 | pmid=30755957 | doi=10.12890/2017_000645 | pmc=6346910 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30755957  }}</ref>
* Absence of other Fabry's disease presentations
*Absence of other Fabry's disease presentations
|
|
|-
|-
|[[Porphyria]]
|[[Porphyria]]
|
|
* The sequence of flares and remission periods in history is important.
|
|
|-
|-
|[[Uremic neuropathy]]
|[[Uremic neuropathy]]
|
|
* The elevated blood uremia level and renal insufficient findings.
|
|
|-
|-
|[[Guillain-Barré syndrome|Guillain-Barre]]' syndrome
|[[Guillain-Barré syndrome|Guillain-Barre]]' syndrome
|
|
* Typical symptoms:
** Both sides of the body
** Change in sensation or pain
** beginning from hands or feeds and spreading to upper parts of the body 
|
|
|-
|-
|Hereditary [[neuropathy]]
|Hereditary [[neuropathy]]
|
|
* Mean age: usually teenage or 20s or 30s
* Mostly affected: legs, feet, elbow wrist, or hand.
|
|
|}
|}

Revision as of 09:42, 17 April 2022

Fabry's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Fabry's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Fabry's disease differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Fabry's disease differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Fabry's disease differential diagnosis

CDC on Fabry's disease differential diagnosis

Fabry's disease differential diagnosis in the news

Blogs on Fabry's disease differential diagnosis

Directions to Hospitals Treating Fabry's disease

Risk calculators and risk factors for Fabry's disease differential diagnosis

Differentiating Fabry's disease from other disease

Organ Sing/Symptom Fabry's disease Possible differential diagnosis DDx Clues Further info
Skin Angiokeratoma
 Fucosidosis[1]
  • Mean age: 2 years old, the older patients more likely to have in examination
  • Location: Varies involve Hips, Groin, Abdomen, external genitalia
  • The clinical appearance of the lesions may be indistinguishable.
  • The light microscopic findings are indistinguishable.
  • Should Investigate accompanying symptoms
Sialidosis (Juvenile foem)[2]
  • Mean age : 2 years old
  • Location: Diffuse
  • The clinical appearance of the lesions may be indistinguishable.
  • Should Investigate accompanying symptoms
Acral pseudolymphomatous angiokeratoma of childhood[3]
  • Mainly children
  • Location: Trunk and exterimities
  • Should Investigate accompanying symptoms
Hypohidrosis/Anhidrosis
  • Mean age: Mostly in the 20s [4]
 Horner syndrome
  • Classic signs: Ptosis, Miosis, Anhidrosis
  • In children and infants Harlequin sign is more apparent than anhidrosis
Topiramate usage
  • History taking
Acetylcholine intoxication
  • History taking
Ectodermal dysplasia
  • Accompanying with hair and teeth problems[5]
Hyperhidrosis
  • More common in females
  • Mean age: Mostly in the 30s
 Primary hyperhidrosis[6]
  • Mean age: before 25
  • Focal
  • Family history of idiopathic hyperhidrosis
Lymphedema
  • Mostly Lower limbs[7]
  • Mean age: 37 in males, 47 in females [8]
 Chronic Venus insufficiency
  • History taking
  • Should Investigate accompanying symptoms
Rheumatic disorders
  • History taking
  • Should Investigate accompanying symptoms
Peripheral nervous system Pain (Neuropathic)
  • Severe neuropathic pain, Limb pain ( Acroparesthesia), Burning palms and soles
  • Exacerbate by high temperature
  • Mean age: 10 years old
 Rheumatic disorders
Fibromyalgia
Headache (Cluster)
  • Attention to cluster diagnostic crateria
Migraine
  • Should Investigate accompanying symptoms
  • Both can have white matter lesions (WML) in MRI[9]
Diabetic neuropathy
  • Chronic progression
  • acute crisis episodes is more favorable in Fabry's disease[10]
Recurrent fever syndromes
  • Elevation of acute phase reactants[11]
  • Absence of other Fabry's disease presentations
Porphyria
  • The sequence of flares and remission periods in history is important.
Uremic neuropathy
  • The elevated blood uremia level and renal insufficient findings.
Guillain-Barre' syndrome
  • Typical symptoms:
    • Both sides of the body
    • Change in sensation or pain
    • beginning from hands or feeds and spreading to upper parts of the body
Hereditary neuropathy
  • Mean age: usually teenage or 20s or 30s
  • Mostly affected: legs, feet, elbow wrist, or hand.

References

  1. ↑ Stepien KM, Ciara E, Jezela-Stanek A (2020). "Fucosidosis-Clinical Manifestation, Long-Term Outcomes, and Genetic Profile-Review and Case Series". Genes (Basel). 11 (11). doi:10.3390/genes11111383. PMC 7700486 Check |pmc= value (help). PMID 33266441 Check |pmid= value (help).
  2. ↑ Zampetti A, Orteu CH, Antuzzi D, Bongiorno MR, Manco S, Gnarra M; et al. (2012). "Angiokeratoma: decision-making aid for the diagnosis of Fabry disease". Br J Dermatol. 166 (4): 712–20. doi:10.1111/j.1365-2133.2012.10742.x. PMID 22452439.
  3. ↑ Chedraoui A, Malek J, Tamraz H, Zaynoun S, Kibbi AG, Ghosn S (2010). "Acral pseudolymphomatous angiokeratoma of children in an elderly man: report of a case and review of the literature". Int J Dermatol. 49 (2): 184–8. doi:10.1111/j.1365-4632.2009.04203.x. PMID 20465644.
  4. ↑ Orteu CH, Jansen T, Lidove O, Jaussaud R, Hughes DA, Pintos-Morell G; et al. (2007). "Fabry disease and the skin: data from FOS, the Fabry outcome survey". Br J Dermatol. 157 (2): 331–7. doi:10.1111/j.1365-2133.2007.08002.x. PMID 17573884.
  5. ↑ Kohn LL, Braun M, Cordoro KM, McCalmont TH, Shah SD, Frieden IJ; et al. (2022). "Skin and Mucosal Manifestations in NEMO Syndrome: A Case Series and Literature Review". Pediatr Dermatol. 39 (1): 84–90. doi:10.1111/pde.14905. PMID 34989033 Check |pmid= value (help).
  6. ↑ Gorelick J, Friedman A (2020). "Diagnosis and Management of Primary Hyperhidrosis: Practical Guidance and Current Therapy Update". J Drugs Dermatol. 19 (7): 704–710. doi:10.36849/JDD.2020.5162. PMID 32726555 Check |pmid= value (help).
  7. ↑ Chabás A, Coll MJ, Aparicio M, Rodriguez Diaz E (1994). "Mild phenotypic expression of alpha-N-acetylgalactosaminidase deficiency in two adult siblings". J Inherit Metab Dis. 17 (6): 724–31. doi:10.1007/BF00712015. PMID 7707696.
  8. ↑ Orteu CH, Jansen T, Lidove O, Jaussaud R, Hughes DA, Pintos-Morell G; et al. (2007). "Fabry disease and the skin: data from FOS, the Fabry outcome survey". Br J Dermatol. 157 (2): 331–7. doi:10.1111/j.1365-2133.2007.08002.x. PMID 17573884.
  9. ↑ Albano B, Dinia L, Del Sette M, Gandolfo C, Sivori G, Finocchi C (2010). "Fabry disease in patients with migraine with aura". Neurol Sci. 31 Suppl 1: S167–9. doi:10.1007/s10072-010-0314-5. PMID 20464614.
  10. ↑ Burlina AP, Sims KB, Politei JM, Bennett GJ, Baron R, Sommer C; et al. (2011). "Early diagnosis of peripheral nervous system involvement in Fabry disease and treatment of neuropathic pain: the report of an expert panel". BMC Neurol. 11: 61. doi:10.1186/1471-2377-11-61. PMC 3126707. PMID 21619592.
  11. ↑ Graziani F, Ruggio A, Iaconelli A, Verrecchia E, Morrone A, Antuzzi D; et al. (2017). "Anderson-Fabry's Disease: A Rare but Treatable Case of Fever of Unknown Origin". Eur J Case Rep Intern Med. 4 (7): 000645. doi:10.12890/2017_000645. PMC 6346910. PMID 30755957.
Retrieved from "https://www.wikidoc.org/index.php?title=Fabry%27s_disease_differential_diagnosis&oldid=1722575"